A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors von Strosberg, J.R., Weber, J.M., Choi, J., Campos, T.L., Valone, T.L., Han, G., Schell, M.J., Kvols, L.K.

Volltext